C-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis

Cancer Research

Volumn 73, Issue 18, 2013, Pages 5754-5763

  Gavert, Nancy ^a   Shvab, Anna ^a   Sheffer, Michal ^a   Ben Shmuel, Amir ^a   Haase, Gal ^a   Bakos, Eszter ^a   Domany, Eytan ^a   Ben Ze'ev, Avri ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STEM CELL FACTOR; TRANSCRIPTION FACTOR SP1; UVOMORULIN; WNT PROTEIN;

ARTICLE; CANCER TISSUE; CARCINOGENESIS; CARCINOGENICITY; CELL MOTILITY; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL CANCER; DNA MICROARRAY; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LIVER METASTASIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

ANIMALS; APOPTOSIS; BETA CATENIN; BLOTTING, WESTERN; CADHERINS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL NEOPLASMS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MICE; MICE, NUDE; NEURAL CELL ADHESION MOLECULE L1; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-KIT; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84884751378     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-0576     Document Type: Article

References (43)

1. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006;127:469-80.
2. Polakis P. The many ways of Wnt in cancer. Curr Opin Genet Dev 2007;17:45-51.
3. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherin-catenin adhesion system in adhesion, signaling and cancer. J Clin Invest 2002;109:987-991.
4. Conacci-Sorrell ME, Ben-Yedidia T, Shtutman M, Feinstein E, Einat P, Ben-Ze'ev A. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. Genes Dev 2002; 16:2058-72.
5. Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T, et al. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 2005;168:633-42.
6. Gavert N, Sheffer M, Raveh S, Spaderna S, Shtutman M, Brabletz T, et al. Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res 2007;67:7703-12.
7. Gavert N, Ben-Shmuel A, Lemmon V, Brabletz T, Ben-Ze'ev A. NF-kB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells. J Cell Sci 2010;123:2135-43.
8. Ben-Shmuel A, Shvab A, Gavert N, Brabletz T, Ben-Ze'ev A. Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-kB signaling that promotes colon cancer progression. Oncogene 2013;32:3220-30.
9. Ballman KV, Grill DE, Oberg AL, Therneau TM. Faster cyclic lowess: normalizing RNA arrays via linear models. Bioinformatics 2004;20: 2778-86.
10. Zeisel A, Amir A, Kostler WJ, Domany E. Intensity dependent estimation of noise in microarrays improves detection of differentially expressed genes. BMC Bioinform 2010;11:400-15.
11. Hong F, Breitling R. A comparison of meta-analysis methods for detecting differentially expressed genes in microarray experiments. Bioinformatics 2008;24:374-382.
12. Sheffer M, Bacolod MD, Zuk O, Giardina SF, Pincas H, Barany F, et al. Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer. Proc Natl Acad Sci USA 2009;106:7131-6.
13. Lennartsson J, Ronnstrand L. Stem cell factor receptor/c-Kit: from basic science to clinical implications. Physiol Rev 2012;92:1619-49.
14. Huang S, Jean D, Luca M, Tainsky MA, Bar-Eli M. Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis. EMBO J 1998;17:4358-69.
15. Liu S, Wu LC, Pang J, Santhanam R, Schwind S, Wu YZ, et al. Sp1/NFkB/ HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. Cancer Cell 2010;17:333-47.
16. Tapias A, Ciudad C, Roninson I, Noe V. Regulation of Sp1 by cell cycle related proteins. Cell Cycle 2008;7:2856-67.
17. Vermeulen L, De Sousa E, Melo F, van der Heijden M, Cameron K, de Jong JH, et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010;12:468-76.
18. Serve H, Yee NS, Stella G, Sepp-Lorenzino L, Tan JC, Besmer P. Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptormediated proliferation, survival and cell adhesion in mast cells. EMBO J 1995;14:473-83.
19. Blume-Jensen P, Jiang G, Hyman R, Lee KF, O'Gorman S, Hunter T. Kit/stem cell factor receptor-induced activation of phosphatidylinositol 30-kinase is essential for male fertility. Nat Genet 2000;24:157-62.
20. Lev S, Givol D, Yarden Y. Interkinase domain of kit contains the binding site for phosphatidylinositol 3 kinase. Proc Natl Acad Sci USA 1992; 89:678-82.
21. Raiber EA, Kranaster R, Lam E, Nikan M, Balasubramanian S. A noncanonical DNA structure is a binding motif for the transcription factor SP1 in vitro. Nucleic Acids Res 2012;40:1499-508.
22. Karin M. NF-kB in cancer development and progression. Nature 2006; 441:431-6.
23. Basseres DS, Baldwin AS. NF-kB and inhibitor of kB kinase pathways in oncogenic initiation and progression. Oncogene 2006;25:6817-30.
24. Smalley KS, Sondak VK, Weber JS. c-KIT signaling as the driving oncogenic event in sub-groups of melanomas. Histol Histopathol 2009;24:643-50.
25. Sartini S, Dario B, Morelli M, Da Settimo F, La Motta C. Receptor tyrosine kinase kit and gastrointestinal stromal tumours: an overview. Curr Med Chem 2011;18:2893-903.
26. Maffini MV, Soto AM, Sonnenschein C, Papadopoulos N, Theoharides TC. Lack of c-kit receptor promotes mammary tumors in N-nitrosomethylurea- treated Ws/Ws rats. Cancer Cell Int 2008;8:5.
27. Tsutsui S, Yasuda K, Suzuki K, Takeuchi H, Nishizaki T, Higashi H , et al. A loss of c-kit expression is associated with an advanced stage and poor prognosis on breast cancer. Br J Cancer 2006;94:1874-8.
28. Tonary AM, Macdonald EA, Faught W, Senterman MK, Vanderhyden BC. Lack of expression of c-KIT in ovarian cancers is associated with poor prognosis. Int J Cancer 2000;89:242-50.
29. Medinger M, Kleinschmidt M, Mross K, Wehmeyer B, Unger C, Schaefer HE , et al. c-kit (CD117) expression in human tumors and its prognostic value: an immunohistochemical analysis. Pathol Oncol Res 2010;16:295-301.
30. Friederichs J, von WeyhernCW, Rosenberg R, Doll D, Busch R, Lordick F, et al. Immunohistochemical detection of receptor tyrosine kinases ckit, EGF-R, andPDGF-R in colorectal adenocarcinomas. Langenbecks Arch Surg 2010;395:373-9.
31. Horie K, Fujita J, Takakura K, Kanzaki H, Suginami H, Iwai M, et al. The expression of c-kit protein in human adult and fetal tissues. Hum Rep 1993;8:1955-62.
32. Rothenberg M, Nusse Y, Kalisky T, Lee J, Dalerba P, Scheeren F, et al. Identification of a c-Kit colonic base secretory cell that supports Lgr5 stem cells in mice. Gastroenterology 2012;142:1195-205.
33. Reed J, Ouban A, Schickor F, Muraca P. Immunohistochemical staining for c-Kit (CD117) is a rare event in human colorectal carcinoma. Clin Colorectal Can 2002;2:119-22.
34. Sammarco I, Capurso G, Coppola L, Bonifazi A, Cassetta S, Fave G, et al. Expression of the proto-oncogene c-KIT in normal and tumor tissues from colorectal carcinoma patients. Int J Colorectal Dis 2004;19:545-53.
35. Bellone G, Silvestri S, Artusio E, Tibaudi D, Turletti A, Geuna M, et al. Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-b1. J Cell Physiol 1997;172:1-11.
36. Bellone G, Carbone A, Sibona N, Bosco O, Tibaudi D, Smirne C, et al. Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential. Cancer Res 2001;61: 2200-6.
37. Takaoka A, Toyota M, Hinoda Y, Itoh F, Mita H, Kakiuchi H, et al. Expression and identification of abberant c-kit transcripts in human cancer cells. Cancer Lett 1997;115:257-61.
38. Attoub S, Rivat C, Rodrigues S, Van Bocxlaer S, Bedin M, Bruyneel E, et al. The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy. Cancer Res 2002;62:4879-83.
39. Popow-Wozniak A, Wozniakowska A, Kaczmarek L, Malicka-Blaszkiewicz M, Nowak D. Apoptotic effect of imatinib on human colon adenocarcinoma cells: influence on actin cytoskeleton organization and cell migration. Eur J Pharm 2011;667:66-73.
40. Liu H, Radisky DC, Yang D, Xu R, Radisky ES, Bissell MJ , et al. MYC suppresses cancer metastases by direct transcriptional silencing of av and b3 integrin subunits. Nat Cell Biol 2012;14:567-74.
41. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009;9:265-73.
42. Ocaña OH,Corcoles R, Fabra A, Moreno-Bueno G, Acloque H, Vega S, et al. Metastatic colonization requires the repression of the epithelialmesenchymal transition inducer Prrx1. Cancer Cell 2012;22:709-24.
43. Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 2012;22:725-36.